Error: Could not add to watchlist. X

Candriam Equities L Biotechnology

+ Watchlist
DEXEBTL:LX
384.36
USD
16.36
4.08%
As of 12:59 AM EST on 2/8/2016.
Fund Type
SICAV
52Wk Range
384.36 - 646.38
1 Yr Return
-26.39%
YTD Return
-29.86%
Previous Close
400.72
52Wk Range
384.36 - 646.38
1 Yr Return
-25.77%
YTD Return
-29.86%
Fund Type
SICAV
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
International
NAV (on 02/08/2016)
384.36
Total Assets (m USD) (on 02/08/2016)
448.274
Inception Date
03/21/2011
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
RUDI VAN DEN EYNDE
Front Load Fee
3.50%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.50%
Expense Ratio
-
Top Fund Holdings
Name Position Value % of Fund
Biogen Inc 201.00 k 61.58 m 8.20
Celgene Corp 482.00 k 57.72 m 7.69
Gilead Sciences Inc 560.50 k 56.72 m 7.55
Amgen Inc 331.00 k 53.73 m 7.16
Regeneron Pharmaceuticals Inc 90.00 k 48.86 m 6.51
Alexion Pharmaceuticals Inc 156.00 k 29.76 m 3.96
Vertex Pharmaceuticals Inc 219.00 k 27.56 m 3.67
Incyte Corp 254.00 k 27.55 m 3.67
BioMarin Pharmaceutical Inc 204.90 k 21.47 m 2.86
Illumina Inc 78.80 k 15.13 m 2.01
Profile
Candriam Equities L - Biotechnology is a SICAV incorporated under the laws of Luxembourg. The Fund's objective is capital appreciation. The Fund invests in global biotechnology stocks. Because the sector is currently experiencing the highest growth in the U.S., at least two-thirds of the Fund's assets will be invested in U.S. biotechnology stocks.
ADDRESS
Candriam Luxembourg
136 route d'Arlon
1150 Luxembourg
PHONE
352-254-3431